CVS Health (CVS) Stock Drops Despite Market Gains: Important Facts to Note
https://www.zacks.com/stock/news/2263624/cvs-health-cvs-stock-drops-despite-market-gains-important-facts-to-note?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2263624
Apr 26, 2024 - CVS Health (CVS) closed at $67.18 in the latest trading session, marking a -0.22% move from the prior day.
0
A CVS Health pharmacy in Vegas becomes first to join new national pharmacy union
https://www.cnbc.com/2024/04/26/cvs-omnicare-pharmacy-in-vegas-is-first-to-join-new-pharmacy-union.html
Apr 26, 2024 - Dozens of pharmacy staff at the Las Vegas branch of CVS's Omnicare will now join the Pharmacy Guild, which will represent them in labor negotiations with CVS.
0
Why CVS Health (CVS) Dipped More Than Broader Market Today
https://www.zacks.com/stock/news/2262767/why-cvs-health-cvs-dipped-more-than-broader-market-today?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2262767
Apr 25, 2024 - The latest trading day saw CVS Health (CVS) settling at $67.33, representing a -0.65% change from its previous close.
0
CVS treatment program discriminates against people with HIV, judge says
https://seekingalpha.com/news/4091709-cvs-must-face-hiv-patients-discrimination-suit?source=feed_sector_healthcare
Apr 20, 2024 - CVS Health (CVS) loses bid to avoid claims of discrimination against people with HIV. Read more here.
0
CVS Health (CVS) Ascends While Market Falls: Some Facts to Note
https://www.zacks.com/stock/news/2258769/cvs-health-cvs-ascends-while-market-falls-some-facts-to-note?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2258769
Apr 19, 2024 - In the most recent trading session, CVS Health (CVS) closed at $69.75, indicating a +0.52% shift from the previous trading day.
0
CVS Health (CVS) Rises As Market Takes a Dip: Key Facts
https://www.zacks.com/stock/news/2258053/cvs-health-cvs-rises-as-market-takes-a-dip-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2258053
Apr 18, 2024 - CVS Health (CVS) closed at $69.39 in the latest trading session, marking a +1.15% move from the prior day.
0
CVS favors Humira copycats hurting AbbVie’s market share: Evercore
https://seekingalpha.com/news/4090466-cvs-favors-humira-copycats-hurting-abbvies-market?source=feed_sector_healthcare
Apr 17, 2024 - CVS Health's (CVS)decision to drop coverage for Humira and favor its cheaper biosimilars is hurting AbbVie's (ABBV) market dominance. Read more here.
0
CVS Health (CVS) Declines More Than Market: Some Information for Investors
https://www.zacks.com/stock/news/2254862/cvs-health-cvs-declines-more-than-market-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2254862
Apr 12, 2024 - In the closing of the recent trading day, CVS Health (CVS) stood at $68.64, denoting a -1.58% change from the preceding trading day.
0
CVS Health (CVS) Stock Drops Despite Market Gains: Important Facts to Note
https://www.zacks.com/stock/news/2252981/cvs-health-cvs-stock-drops-despite-market-gains-important-facts-to-note?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2252981
Apr 09, 2024 - CVS Health (CVS) closed at $73.36 in the latest trading session, marking a -1.45% move from the prior day.
0
Fastenal (FAST) to Post Q1 Earnings: What's in the Cards?
https://www.zacks.com/stock/news/2252013/fastenal-fast-to-post-q1-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2252013
Apr 08, 2024 - Fastenal's (FAST) Q1 results are likely to reflect manufacturing growth, albeit at a slow pace, with a strong digital strategy and a balanced onsite/offsite mix. Yet, slowing industrial markets are a concern.
0
Page 1>